European Journal of Internal Medicine, 2023 Clinical features and immune mechanisms directly linked to the altered liver function in patients with rheumatoid arthritis Arias-de la Rosa I., Ruiz-Ponce M., Cuesta-López L. et al. Olink Target 96Immunological & Inflammatory DiseasesHepatologyPathophysiologyCell Culture Supernatant | | | | |
BMC Medicine, 2023 Decreased TMIGD1 aggravates colitis and intestinal barrier dysfunction via the BANF1-NF-κB pathway in Crohn’s disease Zhou L., Zhu L., Wu X. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySerum | | | | |
Clinical Cancer Research, 2023 Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients Sarén T., Ramachandran M., Gammelgård G. et al. Olink Target 96OncologyPathophysiologyPlasma | | | | |
Frontiers in Cardiovascular Medicine, 2023 Baseline fibroblast growth factor 23 is associated with long-term mortality in ST-elevation myocardial infarction—results from the augsburg myocardial infarction registry Schmitz T., Wein B., Heier M. et al. Olink Target 96CVDPathophysiologyPatient StratificationPlasma | | | | |
Clinical Cancer Research, 2023 A Phase II Trial of the CD40 Agonistic Antibody Sotigalimab (APX005M) in Combination with Nivolumab in Subjects with Metastatic Melanoma with Confirmed Disease Progression on Anti-PD-1 Therapy Weiss S., Sznol M., Shaheen M. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPlasma | | | | |
Clinical Journal of the American Society of Nephrology, 2023 Differences in the Circulating Proteome in Individuals with versus without Sickle Cell Trait Cai Y., Franceschini N., Surapaneni A. et al. Olink Explore 3072/384NephrologyHematologyPathophysiologyPlasma | | | | |
Cytokine, 2023 The role of NLRP3 in regulating gingival epithelial cell responses evoked by Aggregatibacter actinomycetemcomitans Jayaprakash Demirel K., Wu R., Neves Guimaraes A. et al. Olink Target 96Infectious DiseasesPathophysiologyCell Culture Supernatant | | | | |
Allergy, 2023 Mechanisms of gut epithelial barrier impairment caused by food emulsifiers polysorbate 20 and polysorbate 80 Ogulur I., Yazici D., Pat Y. et al. Olink Target 96Nutritional SciencePathophysiologyCell Culture Supernatant | | | | |
International Immunopharmacology, 2023 Cytokine patterns in the blister fluid and plasma of patients with fracture blisters Li Y., Long Y., Chen X. et al. Olink Target 96Other Diseases & SyndromesPathophysiologyPlasmaFracture Blister Fluid | | | | |
Journal of Allergy and Clinical Immunology, 2023 Integrated proteomics and genomics analysis of paradoxical eczema in psoriasis patients treated with biologics Al-Janabi A., Martin P., Khan A. et al. Olink Target 96Dermatological DiseasesPathophysiologySerum | | | | |
Cytokine, 2023 Lower levels of Th1 and Th2 cytokines in cerebrospinal fluid (CSF) at the time of initial CSF shunt placement in children are associated with subsequent shunt revision surgeries Simon T., Sedano S., Rosenberg-Hasson Y. et al. Olink Target 96NeurologyPatient StratificationCSF | | | | |
European Journal of Immunology, 2023 Proteomics reveals a global phenotypic shift of NK cells in HCV patients treated with direct‐acting antivirals Bi W., Kraft A., Engelskircher S. et al. Olink Target 96Infectious DiseasesPathophysiologyPlasma | | | | |
Clinical and Molecular Allergy, 2023 Systemic inflammatory proteins in offspring following maternal probiotic supplementation for atopic dermatitis prevention Zakiudin D., Rø A., Videm V. et al. Olink Target 96Dermatological DiseasesPathophysiologyPlasma | | | | |
JAMA Network Open, 2023 Biomarkers Associated With Severe COVID-19 Among Populations With High Cardiometabolic Risk Sood T., Perrot N., Chong M. et al. Olink Target 96Infectious DiseasesPathophysiologyPlasma | | | | |
Hematological Oncology, 2023 Safety and efficacy of parsaclisib in combination with obinutuzumab and bendamustine in patients with relapsed or refractory follicular lymphoma (CITADEL‐102): A phase 1 study Hamadani M., Coleman M., Boccia R. et al. Olink Target 96OncologyPathophysiologyPlasma | | | | |
eBioMedicine, 2023 Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccination Duran-Castells C., Prats A., Oriol-Tordera B. et al. Olink Target 96Infectious DiseasesPathophysiologyPlasma | | | | |
Journal of Circulating Biomarkers, 2023 Protein Detection Using the Multiplexed Proximity Extension Assay (PEA) from Plasma and Vaginal Fluid Applied to the Indicating FTA Elute Micro Card™ Berggrund M., Ekman D., Gustavsson I. et al. Olink Target 96OncologyTechnology EvaluationPlasmaVaginal Fluid | | | | |
Translational Research, 2023 Plasma protein signatures reflect systemic immunity and allograft function in kidney transplantation Buscher K., Rixen R., Schütz P. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Frontiers in Immunology, 2023 Multi-omic analysis of the tumor microenvironment shows clinical correlations in Ph1 study of atezolizumab +/- SoC in MM Wong S., Hamidi H., Costa L. et al. Olink Target 96OncologyImmunotherapyPathophysiologyBone Marrow Plasma | | | | |
Journal of the American Heart Association, 2023 Novel Biomarkers of Necrotizing Enterocolitis in Neonates Undergoing Congenital Heart Disease Surgery: A Pilot Cohort Study Ali E., Syed A., Khailova L. et al. Olink Explore 3072/384CVDPathophysiologyPatient StratificationPlasma | | | | |